IMO ... and it is just that ..... CLBP relief for even 6 months after a stem cell treatment would still negate the need for these patients to use opioids during this period and subsequently contribute to the decline in opioid dependence / abuse ... our previous trials had exceptional results beyond this time frame !!
A reduction in overall opioid use / abuse is a not only a key focus of the FDA right now, but also for other countries as well (e.g. Australia) .... I wouldn’t be at all surprised if the FDA is communicating a willingness to assist MSB where it can with MPC -06 ID ..... e.g Fast Tracking or RMAT designation ?
GLTAH
IMO ... and it is just that ..... CLBP relief for even 6 months...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.038(3.64%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.727M | 3.492M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 36224 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 14070 | 6 |
View Market Depth
| Last trade - 12.28pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |